Please login to the form below

Not currently logged in
Email:
Password:

Global academic research alliance to speed drug development

Includes centres from UK, US, Canada, Germany and Belgium

Global Alliance of Leading Drug Discovery and Development Centres

Six of the world's leading centres in academic and not-for-profit research have come together in a bid to speed up the process by which academic research is translated into usable medicines.

The Global Alliance of Leading Drug Discovery and Development Centres comprises organisations from both Europe and North America, including Canada's Centre for Drug Research and Development (CDRD), the Scripps Research Institute of the US and Germany's Lead Discovery Centre.

Belgium's Centre for Drug Design and Discovery (CD3), and the UK's Medical Research Council (MRC) Technology and Cancer Research Technology (CRT) complete the list of founding members, all of which have experience in advancing early research into drug candidates with proof-of-concept trials.

In total, nearly 400 individual drug developers are represented by the Alliance, with the number of current therapeutic projects standing at 165.

The group's aim is to boost collaboration between member organisations on existing and future projects, including the sharing of best practice, expertise and resources.

It is hoped that all parties will agree a common set of standards and performance measurements, helping to achieve the Alliance's goal of turning global early-stage technology into new therapies for patients.

Other specific objectives include increasing the number of both licensed patents and spin-out companies from academic sources and improving their viability.

There should also be more risk-sharing collaborations with the pharmaceutical and biotech industries, the Alliance said.

“We see a multitude of translational research initiatives around the world, but until now, these have for the most part, worked in isolation of one another,” said Karimah Es Sabar, president and CEO of Canada's CDRD.

“This alliance will be a powerful vehicle in bringing such organisations together, leveraging one another's strengths, and ultimately making for a much more effective global translational research environment.”

22nd January 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...

Infographics